Related Experiment Video
Updated: Oct 27, 2025

Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools
Published on: October 1, 2007
Innovate to secure the future: the future of modern medicine
Sally C Davies1, Claire Oxlade2
1Department of Health and Social Care London, UK.
Abstract:
As drug-resistant pathogens emerge and spread globally, antimicrobial (especially antibiotic) treatments are becoming less effective. As infections become more complex and costly to treat in humans and animals, antimicrobial resistance (AMR) is a global challenge of real and increasing scale and complexity. If we do not act for the long term and with sustainability in mind, the annual deaths we see currently, numbering 700,000 globally, will rise each year to 10 million by 2050. To effectively contain and mitigate AMR, we need more evidence of the drivers and impacts of AMR on human, animal and environmental health, and the links between them. We also need to turn evidence into action and tailored, sustainable approaches for countries and communities, which put clinicians and patients at the centre. Excellent research is underway across the world into innovation (including new treatments, diagnostics and vaccines), infection prevention and behavioural interventions. In this article, we explore how, where and why research should be intensified, with increased collaboration and transparency, to strengthen global health security and secure the future of modern medicine for patients globally.
Insights
Antimicrobial resistance (AMR) threatens global health, with deaths projected to reach 10 million by 2050. Intensified research, collaboration, and evidence-based action are crucial to combat this growing challenge and protect modern medicine.
Area of Science:
- Global Health Security
- Infectious Disease Epidemiology
- One Health Approach
Background:
- Antimicrobial resistance (AMR) is a growing global threat, diminishing the effectiveness of treatments for humans and animals.
- Current annual deaths from AMR reach 700,000, with projections indicating a rise to 10 million by 2050 without intervention.
- The complexity and cost of treating infections are increasing due to widespread drug resistance.
Purpose of the Study:
- To highlight the urgent need for intensified research into the drivers and impacts of AMR.
- To emphasize the necessity of translating evidence into sustainable, tailored actions for human, animal, and environmental health.
- To advocate for increased collaboration and transparency in AMR research to strengthen global health security.
Main Methods:
- Review of current global AMR research landscape.
- Analysis of the interconnectedness of AMR across human, animal, and environmental health sectors.
- Exploration of strategies for intensifying research and translating findings into practice.
Main Results:
- Significant research is ongoing globally in areas like new treatments, diagnostics, vaccines, and behavioral interventions.
- There is a critical need for more evidence on AMR drivers and impacts, particularly the links between different health sectors.
- Effective containment requires turning evidence into actionable, sustainable strategies centered on clinicians and patients.
Conclusions:
- Intensified, collaborative, and transparent research is essential to mitigate AMR.
- A One Health approach is vital to address the complex drivers and impacts of AMR.
- Strengthening global health security relies on securing the future of modern medicine through sustained action against AMR.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Microorganisms in Medicine and Therapeutics
Current Trends in Nursing II
Introduction To Health Care Delivery System
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Current Trends in Nursing I

